A survey of pharmacists' roles in gastroenterology and hepatology

被引:2
作者
Choi, David [1 ]
Patel, Shivani [2 ]
Trivedi, Itishree [1 ]
Rubin, David T. [2 ]
Moss, Alan [3 ,4 ]
Bhat, Shubha [5 ,6 ]
机构
[1] Univ Illinois, Dept Med, Div Gastroenterol & Hepatol, Chicago, IL USA
[2] Univ Chicago, Med Inflammatory Bowel Dis Ctr, Chicago, IL 60637 USA
[3] Boston Univ, Sch Med, Dept Med, Boston Med Ctr, Boston, MA 02118 USA
[4] Boston Univ, Sch Med, Sect Gastroenterol, Boston Med Ctr, Boston, MA 02118 USA
[5] Cleveland Clin, Dept Pharm, Digest Dis & Surg Inst, Cleveland, OH 44106 USA
[6] Cleveland Clin, Dept Gastroenterol, Digest Dis & Surg Inst, Cleveland, OH 44106 USA
来源
JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY | 2021年 / 4卷 / 10期
关键词
clinical pharmacist; gastroenterology; hepatitis C virus; hepatology; inflammatory bowel disease; CLINICAL PHARMACIST; NATIONAL-SURVEY; CARE; SERVICES; CENTERS; DISEASE;
D O I
10.1002/jac5.1499
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction Pharmacists' roles have evolved over time to include direct patient care and optimization of medication related outcomes. However, one therapeutic area lacking an evaluation of pharmacist involvement is gastroenterology and hepatology (GI/liver). This area utilizes biologics and other treatment options with considerable cost and safety, thus pharmacists can have a significant impact in caring for patients with GI/liver conditions. Objectives Identify the background training of pharmacists practicing in GI/liver and characterize their current practice landscape. Methods A survey was developed and disseminated through the American College of Clinical Pharmacy (ACCP) GI/Liver/Nutrition and Ambulatory Practice and Research Networks (PRN) groups and through the American Society of Health System Pharmacists (ASHP) Section of Specialty Pharmacy Practitioners from November 30, 2020 to January 16, 2021. Results Of 42 unique responses received, respondents primarily practiced at an academic medical center in the ambulatory setting. Although respondents reported completing various types of post-graduate training (residency and fellowship), 55% of respondents endorsed prior exposure to GI/liver during training. Common disease states managed were inflammatory bowel disease, hepatitis B and C, and cirrhosis. Half of respondents reported having a collaborative practice agreement and 67% reported independently seeing patients in clinic, developing therapy plans, and ordering/monitoring labs. Approximately 69% do not have dedicated time for research. Only 23% of respondents reported billing for clinical services. Conclusion In this survey, pharmacists are involved in caring for patients with GI/liver conditions under collaborative practice agreements and primarily based in an outpatient clinic. Future growth of pharmacists in this therapeutic space will require increased formalized training of GI/liver conditions and strategies to optimize reimbursement.
引用
收藏
页码:1280 / 1286
页数:7
相关论文
共 27 条
[1]   The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017 [J].
Alatab, Sudabeh ;
Sepanlou, Sadaf G. ;
Ikuta, Kevin ;
Vahedi, Homayoon ;
Bisignano, Catherine ;
Safiri, Saeid ;
Sadeghi, Anahita ;
Nixon, Molly R. ;
Abdoli, Amir ;
Abolhassani, Hassan ;
Alipour, Vahid ;
Almadi, Majid A. H. ;
Almasi-Hashiani, Amir ;
Anushiravani, Amir ;
Arabloo, Jalal ;
Atique, Suleman ;
Awasthi, Ashish ;
Badawi, Alaa ;
Baig, Atif A. A. ;
Bhala, Neeraj ;
Bijani, Ali ;
Biondi, Antonio ;
Borzi, Antonio M. ;
Burke, Kristin E. ;
Carvalho, Felix ;
Daryani, Ahmad ;
Dubey, Manisha ;
Eftekhari, Aziz ;
Fernandes, Eduarda ;
Fernandes, Joao C. ;
Fischer, Florian ;
Haj-Mirzaian, Arvin ;
Haj-Mirzaian, Arya ;
Hasanzadeh, Amir ;
Hashemian, Maryam ;
Hay, Simon, I ;
Hoang, Chi L. ;
Househ, Mowafa ;
Ilesanmi, Olayinka S. ;
Balalami, Nader Jafari ;
James, Spencer L. ;
Kengne, Andre P. ;
Malekzadeh, Masoud M. ;
Merat, Shahin ;
Meretoja, Tuomo J. ;
Mestrovic, Tomislav ;
Mirrakhimov, Erkin M. ;
Mirzaei, Hamed ;
Mohammad, Karzan A. ;
Mokdad, Ali H. .
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2020, 5 (01) :17-30
[2]  
American Society of Health-System Pharmacists, POL POS ASHP 1982 20
[3]  
[Anonymous], 2020, Am J Health Syst Pharm, V77, P113, DOI 10.1093/ajhp/zxz271
[4]   Impact of Clinical Pharmacists in Inflammatory Bowel Disease Centers During the COVID-19 Pandemic [J].
Bhat, Shubha ;
Farraye, Francis A. ;
Moss, Alan C. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 (09) :1532-1533
[5]  
Bott Anne Marie, 2019, Fed Pract, V36, P471
[6]   Evolution of Clinical Pharmacy in the USA and Future Directions for Patient Care [J].
Carter, Barry L. .
DRUGS & AGING, 2016, 33 (03) :169-177
[7]   An Opinion Paper Outlining Recommendations for Training, Credentialing, and Documenting and Justifying Critical Care Pharmacy Services [J].
Dager, William ;
Bolesta, Scott ;
Brophy, Gretchen ;
Dell, Kamila ;
Gerlach, Anthony ;
Kristeller, Judith ;
Micek, Scott ;
Hess, Mary ;
Bentley, Michael ;
Juang, Paul ;
MacLaren, Robert ;
Kane-Gill, Sandra ;
Haase, Krystal ;
Mann, Henry ;
Miller, Colby ;
Pepe, Diane ;
Southwood, Robin ;
Weant, Kyle ;
Rebuck, Jill ;
Wood, Christopher .
PHARMACOTHERAPY, 2011, 31 (08) :829-829
[8]   Improvement in Safety Monitoring of Biologic Response Modifiers After the Implementation of Clinical Care Guidelines by a Specialty Pharmacy Service in an Academic Health System [J].
Hanson, Rebekah L. ;
Gannon, Michael J. ;
Khamo, Nehrin ;
Sodhi, Monsheel ;
Orr, Alexander M. ;
Stubbings, JoAnn .
JOURNAL OF MANAGED CARE PHARMACY, 2013, 19 (01) :49-67
[9]   Pharmacists' roles in oncology pharmacy services: Results of a global survey [J].
Hone, Lisa M. ;
Harris, Christy S. ;
Chan, Alexandre ;
Fahrenbruch, Rebecca J. ;
Labdi, Bonnie A. ;
Mohs, Jocelyn E. ;
Norris, Leann B. ;
Perkins, Janelle ;
Vela, Cory M. .
JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2017, 23 (03) :185-194
[10]   ASHP survey ambulatory care pharmacy practice in health systems - 2004 [J].
Knapp, KK ;
Okamoto, MP ;
Black, BL .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2005, 62 (03) :274-284